pyrazinamide has been researched along with Carcinoma, Squamous Cell in 1 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thakur, BK | 1 |
| Verma, S | 1 |
1 other study available for pyrazinamide and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
BCG-induced lupus vulgaris complicated by squamous cell carcinoma in a 7-year-old child.
Topics: Antitubercular Agents; BCG Vaccine; Carcinoma, Squamous Cell; Child; Ethambutol; Humans; Isoniazid; | 2011 |